Immunofluorescence, WB, and proteomic assays all confirmed that the deletion of RNASET2 significantly increased the expression of MET in HCC cells compared to the control group (Figure 5B–E; Figure S7D,E, Supporting Information). The gene discussed is MET; the disease is hepatocellular carcinoma.